Angiotech calls all 9% floaters due 2013, 9% senior notes due 2016

By Toni Weeks

San Luis Obispo, Calif., April 15 - Angiotech Pharmaceuticals, Inc. plans to redeem the remaining $44,024,000 of its senior secured floating-rate notes due 2013, according to a press release.

The company also said it will fully redeem the outstanding $229,413,000 of 9% senior notes due 2016 issued by Angiotech Pharmaceuticals (US), Inc.

Both series will be redeemed May 13 at par plus accrued interest.

Deutsche Bank National Trust Co. is the trustee.

Angiotech makes medical devices and is based in Vancouver, B.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.